Best Growth Hormone Peptides 2026

The CJC-1295 + Ipamorelin stack is widely considered the gold standard for GH secretagogue research. CJC-1295 stimulates the GHRH receptor for sustained GH elevation, while Ipamorelin selectively activates the ghrelin receptor without cortisol or prolactin elevation. Together they produce synergistic GH output.

Each has distinct advantages. CJC-1295 provides longer-lasting, sustained GH elevation through the GHRH pathway. Ipamorelin offers superior selectivity with GH release that does not affect cortisol or prolactin levels. The choice depends on whether your research priorities are total GH output (CJC-1295) or hormonal specificity (Ipamorelin).

GH secretagogues stimulate the pituitary to release GH in natural pulsatile patterns, maintaining the body's feedback regulation. Exogenous GH bypasses this regulation with continuous exposure. Secretagogue research focuses on maintaining physiological GH patterns rather than supraphysiological levels.

Most research protocols administer GH secretagogues in the evening to align with the body's natural nocturnal GH pulse cycle. The pituitary is most responsive to GHRH and ghrelin signalling during the early sleep period. ORYN pen systems support precise timing for circadian-aligned protocols.